Search results
Results from the WOW.Com Content Network
There are 124 potential Alzheimer’s treatments now being tested in clinical trials to target beta-amyloid and tau, reduce inflammation, protect neurons, act on genes that increase Alzheimer’s ...
An estimated 6.5 million people in the U.S. age 65 and older are currently living with Alzheimer's, underscoring the sales potential for Biogen domestically alone. ... the latest stock market news ...
A new Alzheimer's drug, combined COVID and flu vaccine update, and salmonella concerns. 3 health stories you may have missed — and why they matter Kaitlin Reilly June 15, 2024 at 9:50 AM
‘If the vaccine could prove successful in humans, it would be a big step forward towards delaying disease progression’ New vaccine could be key to preventing Alzheimer’s disease, scientists ...
Associated Press Finance 43 minutes ago Stock market today: Asian shares advance on back of Wall St's rally and upbeat Chinese factory data. Asian shares started the week with solid gains after Wall Street closed its dreary February on a brighter note. Upbeat Chinese factory data also lifted sentiment, helping to s…
Yahoo Finance Live anchors discuss Biogen stock performance on promising Alzheimer’s drug trial data.
How does Eli Lilly (NYSE: LLY) follow up on gains of close to 60% in 2023 and so far in 2024? By winning a major U.S. Food and Drug Administration (FDA) approval. Last week, the FDA approved Lilly ...
AC Immune SA (NASDAQ: ACIU) soars in premarket on robust volume, on the heels of positive interim results from its ongoing Phase 1b/2a trial evaluating its anti-phospho-Tau (pTau) vaccine ...